These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1445599)

  • 61. Mycobacterium avium resists exposure to the acidic conditions of the stomach.
    Bodmer T; Miltner E; Bermudez LE
    FEMS Microbiol Lett; 2000 Jan; 182(1):45-9. PubMed ID: 10612729
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effectiveness of ofloxacin against Mycobacterium tuberculosis and Mycobacterium avium, and rifampin against M. tuberculosis in cultured human macrophages.
    Crowle AJ; Elkins N; May MH
    Am Rev Respir Dis; 1988 May; 137(5):1141-6. PubMed ID: 3143278
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Post-antibiotic effect of imipenem, amikacin and ciprofloxacin against various strains of Serratia marcescens].
    Bollet C; Mallet MN; Bouchemal H; de Micco P
    Pathol Biol (Paris); 1990 May; 38(5):446-9. PubMed ID: 2195454
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [A susceptibility study of Mycobacterium avium-intracellulare strains using the broth macrodilution method].
    Mederos Cuervo LM; Ferrá Salazar C; Jimenez Misas CA; Valdivia Alvarez JA
    Rev Cubana Med Trop; 1995; 47(1):54-8. PubMed ID: 9805069
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Stazyme, a mycobacteriolytic preparation from a Staphylococcus strain, is able to break the permeability barrier in multiple drug resistant Mycobacterium avium.
    Rastogi N; Goh KS; Clavel-Sérès S
    FEMS Immunol Med Microbiol; 1997 Dec; 19(4):297-305. PubMed ID: 9537755
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Activity of amikacin against Mycobacterium avium complex under simulated in vivo conditions.
    Gangadharam PR; Kesavalu L; Rao PN; Perumal VK; Iseman MD
    Antimicrob Agents Chemother; 1988 Jun; 32(6):886-9. PubMed ID: 3415209
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clofazimine and other rimino-compounds: minimal inhibitory and minimal bactericidal concentrations at different pHs for Mycobacterium avium complex.
    Lindholm-Levy PJ; Heifets LB
    Tubercle; 1988 Sep; 69(3):179-86. PubMed ID: 3254636
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Comparison of a Novel Regimen of Rifapentine, Tedizolid, and Minocycline with Standard Regimens for Treatment of Pulmonary Mycobacterium kansasii.
    Chapagain M; Gumbo T; Heysell SK; Srivastava S
    Antimicrob Agents Chemother; 2020 Sep; 64(10):. PubMed ID: 32690646
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comparative uptake of rifampicin and rifapentine (DL473) by human neutrophils.
    Easmon CS; Crane JP
    J Antimicrob Chemother; 1984 Jun; 13(6):585-91. PubMed ID: 6469880
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Post-Antibiotic and Post-Antibiotic Sub-Minimum Inhibitory Concentration Effects of Carvacrol against
    Boyer E; Galán-Relaño Á; Romero-Salmoral A; Barraza P; Gómez-Gascón L; Tarradas C; Luque I; de Aguiar FC; Huerta Lorenzo B
    Animals (Basel); 2024 Sep; 14(18):. PubMed ID: 39335222
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Liposomal amikacin for treatment of M. avium infections in clinically relevant experimental settings.
    Ehlers S; Bucke W; Leitzke S; Fortmann L; Smith D; Hänsch H; Hahn H; Bancroff G; Müller R
    Zentralbl Bakteriol; 1996 Jul; 284(2-3):218-31. PubMed ID: 8837382
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Resistance and permeability of Mycobacterium avium complex species to 5-fluorouracil.
    Abdulmalek S; McCarthy CM
    J Antimicrob Chemother; 1994 Feb; 33(2):329-35. PubMed ID: 8182015
    [No Abstract]   [Full Text] [Related]  

  • 73. Postantibiotic effect and delay of regrowth in strains carrying mutations that save proteins or RNA.
    Dolcino M; Zoratti A; Debbia EA; Schito GC; Marchese A
    Antimicrob Agents Chemother; 2002 Dec; 46(12):4022-5. PubMed ID: 12435717
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Evidence suggesting that the life span of Mycobacterium avium complex is longer than that of other mycobacteria.
    Tsukamura M
    Microbiol Immunol; 1988; 32(8):769-74. PubMed ID: 3200167
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effects of supra- and sub-MIC benzylpenicillin concentrations on group A beta-haemolytic streptococci during the postantibiotic phase in vivo.
    Odenholt I; Holm SE; Cars O
    J Antimicrob Chemother; 1990 Aug; 26(2):193-201. PubMed ID: 2211456
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Exposure to low oxygen tension and increased osmolarity enhance the ability of Mycobacterium avium to enter intestinal epithelial (HT-29) cells.
    Bermudez LE; Petrofsky M; Goodman J
    Infect Immun; 1997 Sep; 65(9):3768-73. PubMed ID: 9284150
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Interaction of rifampicin or rifapentine with other agents against Pseudomonas aeruginosa.
    Korvick J; Yu VL; Sharp JA
    J Antimicrob Chemother; 1987 Jun; 19(6):847-8. PubMed ID: 3112103
    [No Abstract]   [Full Text] [Related]  

  • 78. Early detection of rifampin in human nerve tissue after an oral dose of 600 milligrams.
    Guebre-Xabier M; Shannon EJ; Kazen R; Kebret Z; Frommel D
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1866-70. PubMed ID: 7486936
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Correction to: Amikacin Liposome Inhalation Suspension: A Review in Mycobacterium avium Complex Lung Disease.
    Shirley M
    Drugs; 2019 May; 79(7):791. PubMed ID: 30941606
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Amikacin liposome inhalation suspension clinical benefit-risk assessment for refractory
    Marras TK; Hassan M; Mange KC; Ciesielska M; Murthy SD; Jumadilova Z; Chatterjee A
    ERJ Open Res; 2022 Jul; 8(3):. PubMed ID: 35821755
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.